Ventyx Biosciences
Price & Volume
Stats
See more52W Range | $0.78-$3.39 |
Market Cap | $188.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.66 |
News
See moreYahoo Finance • 2 months ago
Ventyx reports positive Phase 2a results for Parkinson's drug
Yahoo Finance • 2 months ago
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
Yahoo Finance • 6 months ago
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
Yahoo Finance • 2 years ago
Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference
About
CEO | Dr. Raju S. Mohan Ph.D. |
Address | 12790 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
